SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-21-105909
Filing Date
2021-08-16
Accepted
2021-08-16 11:17:18
Documents
41
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q atxi-20210630x10q.htm   iXBRL 10-Q 1072726
2 EXHIBIT 31.1 atxi-20210630xex31d1.htm EX-31.1 11848
3 EXHIBIT 31.2 atxi-20210630xex31d2.htm EX-31.2 11551
4 EXHIBIT 32.1 atxi-20210630xex32d1.htm EX-32.1 5492
5 EXHIBIT 32.2 atxi-20210630xex32d2.htm EX-32.2 5242
  Complete submission text file 0001104659-21-105909.txt   2911938

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA atxi-20210630.xsd EX-101.SCH 19716
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE atxi-20210630_cal.xml EX-101.CAL 16180
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE atxi-20210630_def.xml EX-101.DEF 80546
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE atxi-20210630_lab.xml EX-101.LAB 165264
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atxi-20210630_pre.xml EX-101.PRE 141772
11 EXTRACTED XBRL INSTANCE DOCUMENT atxi-20210630x10q_htm.xml XML 301847
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 781-652-4500
AVENUE THERAPEUTICS, INC. (Filer) CIK: 0001644963 (see all company filings)

IRS No.: 474113275 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38114 | Film No.: 211175590
SIC: 2834 Pharmaceutical Preparations